Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.
Abdallah MS, Mosalam EM, Hassan A, Ramadan AN, Omara-Reda H, Zidan AA, Samman WA, El-Berri EI. Abdallah MS, et al. Among authors: zidan aa. CNS Neurosci Ther. 2023 Jan;29(1):354-364. doi: 10.1111/cns.14010. Epub 2022 Nov 7. CNS Neurosci Ther. 2023. Retraction in: CNS Neurosci Ther. 2024 Mar;30(3):e14668. doi: 10.1111/cns.14668 PMID: 36341700 Free PMC article. Retracted. Clinical Trial.
The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
Abdallah MS, Mosalam EM, Zidan AA, Elattar KS, Zaki SA, Ramadan AN, Ebeid AM. Abdallah MS, et al. Among authors: zidan aa. Neurotherapeutics. 2020 Oct;17(4):1897-1906. doi: 10.1007/s13311-020-00878-7. Neurotherapeutics. 2020. Retraction in: Neurotherapeutics. 2022 Sep;19(5):1687. doi: 10.1007/s13311-022-01291-y PMID: 32500486 Free PMC article. Retracted. Clinical Trial.
Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
Abdallah MS, Mosalam EM, Zidan AA, Elattar KS, Zaki SA, Ramadan AN, Ebeid AM. Abdallah MS, et al. Among authors: zidan aa. Neurotherapeutics. 2022 Sep;19(5):1687. doi: 10.1007/s13311-022-01291-y. Neurotherapeutics. 2022. PMID: 36071262 Free PMC article. No abstract available.
IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.
Salem ML, Zidan AA, Attia M, El-Naggar RE, Nassef M, Abou El-Azm AR, El-Bate H, Yussif M, Galal S, Abo Senna M, El Demellawy M. Salem ML, et al. Among authors: zidan aa. Immunopharmacol Immunotoxicol. 2017 Aug;39(4):188-198. doi: 10.1080/08923973.2017.1320670. Epub 2017 May 4. Immunopharmacol Immunotoxicol. 2017. PMID: 28472907
37 results